August 30, 2022 — Abbott announced new late-breaking data that show its HeartMate 3 heart pump extends survival of advan ...
August 29, 2022 — Detailed results from the DELIVER Phase III trial showed AstraZeneca’s FARXIGA (dapagliflozin) ...
August 29, 2022 — Medtronic plc announced that its investigational EV ICD System – a first-of-its-kind defibrillator ...
August 29, 2022 — Amarin Corporation plc announced that new REDUCE-IT data show that VASCEPA/VAZKEPA (icosapent ethyl) ...
August 29, 2022 — In a first-of-its-kind randomized clinical trial led by researchers at the Smidt Heart Institute and ...
August 29, 2022 — The US Preventive Services Task Force (USPSTF) has issued a Recommendation Statement, relating to ...
August 26, 2022 — The Cardiovascular Research Foundation (CRF) and Fogarty Innovation announced today that the program ...
August 25, 2022 — The results of “A Phase 3, Open-label, Multicenter Study of Flurpiridaz (F18) Injection for Positron ...
It recently was announced that two leaders in cardiovascular disease science, research and education — the American ...
August 23, 2022 — In a detailed analysis of nearly 43 million people, ages 13 and older, who received at least one dose ...
Hospitals in the U.S. are suffering under a debilitating post-pandemic financial and operational trauma. Ascension poste ...
August 16, 2022 — Two leaders in cardiovascular disease science, research and education, the American Heart Association ...
August 12, 2022 — The results of “A Phase 3, Open-label, Multicenter Study of Flurpiridaz (F18) Injection for Positron ...
August 11, 2022 — The Heart Rhythm Society (HRS) announced the full lineup of speakers and sessions for its first annual ...
August 10, 2022 — On July 27, ASNC joined a coalition of more than 100 medical societies urging Congress to pass ...